... marketing; China's State Intellectual Property Office invalidated the patent for Viread, a treatment for HBV and HIV/AIDS developed by Gilead Sciences; and Johnson & Johnson was ordered to pay a fine for enforcing a minimum price policy on its China ...
http://www.biospace.com/news_story.aspx?StoryID=304819&full=1
http://www.biospace.com/news_story.aspx?StoryID=304819&full=1
No comments:
Post a Comment